Under physiological conditions hypothalamic stimuli trigger GH synthesis by activating the cAMP/PKA-signaling cascade and somatostatin analogs that inhibit this pathway are the mainstay pharmacological treatment for patients with acromegaly [10]. The gene discussed is GH1; the disease is acromegaly.